{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T10:59:37Z","timestamp":1764586777638},"reference-count":39,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jim.2013.01.008","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T21:33:44Z","timestamp":1359149624000},"page":"52-62","source":"Crossref","is-referenced-by-count":7,"title":["A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses"],"prefix":"10.1016","volume":"390","author":[{"given":"Daniel","family":"Smr\u017e","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geethani","family":"Bandara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly A.","family":"Mock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Beaven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alasdair M.","family":"Gilfillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2013.01.008_bb0005","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1182\/blood-2008-08-175190","article-title":"Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs","volume":"114","author":"Aichberger","year":"2009","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1016\/j.jim.2013.01.008_bb0010","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/modpathol.2008.9","article-title":"Targeted therapy of cancer: new roles for pathologists in identifying GISTs and other sarcomas","volume":"21","author":"Antonescu","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jim.2013.01.008_bb0015","article-title":"Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activation","author":"Bai","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jim.2013.01.008_bb0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri2018","article-title":"Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data","volume":"7","author":"Bischoff","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0025","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1158\/1541-7786.MCR-09-0138","article-title":"The aberrant localization of oncogenic kit tyrosine kinase receptor mutants is reversed on specific inhibitory treatment","volume":"7","author":"Bougherara","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jim.2013.01.008_bb0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000315946","article-title":"Mastocytosis","volume":"95","author":"Brockow","year":"2010","journal-title":"Chem. Immunol. Allergy"},{"key":"10.1016\/j.jim.2013.01.008_bb0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2222.2007.02886.x","article-title":"The mast cell and allergic diseases: role in pathogenesis and implications for therapy","volume":"38","author":"Brown","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jim.2013.01.008_bb0040","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.4049\/jimmunol.151.10.5586","article-title":"Antigen and carbachol mobilize calcium by similar mechanisms in a transfected mast cell line (RBL-2H3 cells) that expresses ml muscarinic receptors","volume":"151","author":"Choi","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0045","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/eji.201040559","article-title":"Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity","volume":"40","author":"Galli","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0050","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.jim.2013.01.008_bb0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1615\/CritRevImmunol.v31.i6.30","article-title":"Regulation of mast cell responses in health and disease","volume":"31","author":"Gilfillan","year":"2011","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.2008.00742.x","article-title":"The tyrosine kinase network regulating mast cell activation","volume":"228","author":"Gilfillan","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jim.2013.01.008_bb0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nri1782","article-title":"Integrated signalling pathways for mast-cell activation","volume":"6","author":"Gilfillan","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0070","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3324\/haematol.11339","article-title":"Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT","volume":"92","author":"Gleixner","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jim.2013.01.008_bb0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2012.00119","article-title":"Mast cell chemotaxis \u2014 chemoattractants and signaling pathways","volume":"3","author":"Halova","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0080","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2004-02-0631","article-title":"Kit and Fc\u03b5RI mediate unique and convergent signals for release of inflammatory mediators from human mast cells","volume":"104","author":"Hundley","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jim.2013.01.008_bb0085","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.4049\/jimmunol.1103366","article-title":"Stem cell factor programs the mast cell activation phenotype","volume":"188","author":"Ito","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0090","doi-asserted-by":"crossref","first-page":"40261","DOI":"10.1074\/jbc.M506063200","article-title":"Btk plays a crucial role in the amplification of Fc\u03b5RI-mediated mast cell activation by kit","volume":"280","author":"Iwaki","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2013.01.008_bb0095","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/bjp.2008.204","article-title":"Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders","volume":"154","author":"Jensen","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jim.2013.01.008_bb0100","first-page":"105","article-title":"Growth of human mast cells from bone marrow and peripheral blood-derived CD34+ pluripotent progenitor cells","volume":"315","author":"Kirshenbaum","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jim.2013.01.008_bb0105","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood.V94.7.2333.419k30_2333_2342","article-title":"Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13)","volume":"94","author":"Kirshenbaum","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jim.2013.01.008_bb0110","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.4049\/jimmunol.134.5.3130","article-title":"Production of interleukin 3 and gamma-interferon by an antigen-specific mouse suppressor T cell clone","volume":"134","author":"Koyasu","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0115","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cellsig.2007.11.016","article-title":"Synergistic activation of phospholipases C\u03b3 and C\u03b2: a novel mechanism for PI3K-independent enhancement of Fc\u03b5RI-induced mast cell mediator release","volume":"20","author":"Kuehn","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jim.2013.01.008_bb0120","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1242\/jcs.071043","article-title":"Btk-dependent Rac activation and actin rearrangement following Fc\u03b5RI aggregation promotes enhanced chemotactic responses of mast cells","volume":"123","author":"Kuehn","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jim.2013.01.008_bb0125","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri1460","article-title":"Mast-cell responses to pathogens","volume":"4","author":"Marshall","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0130","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.4049\/jimmunol.180.8.5466","article-title":"Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens","volume":"180","author":"Mayerhofer","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IR:34:2:97","article-title":"Development, migration, and survival of mast cells","volume":"34","author":"Okayama","year":"2006","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jim.2013.01.008_bb0140","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4049\/jimmunol.0902931","article-title":"Glycogen synthase kinase 3\u03b2 activation is a prerequisite signal for cytokine production and chemotaxis in human mast cells","volume":"184","author":"R\u00e5dinger","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0145","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jaci.2006.04.015","article-title":"Molecular regulation of mast cell activation","volume":"117","author":"Rivera","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0150","doi-asserted-by":"crossref","first-page":"10487","DOI":"10.1074\/jbc.M611090200","article-title":"Non-apoptotic phosphatidylserine externalization induced by engagement of glycosylphosphatidylinositol-anchored proteins","volume":"282","author":"Smr\u017e","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2013.01.008_bb0155","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1002\/eji.201040573","article-title":"TLR-mediated signaling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release","volume":"40","author":"Smr\u017e","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0160","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1182\/blood-2011-06-359984","article-title":"mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells","volume":"118","author":"Smr\u017e","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jim.2013.01.008_bb0165","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","article-title":"IgE, mast cells, basophils, and eosinophils","volume":"125","author":"Stone","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2013.01.008_bb0170","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1074\/jbc.M808058200","article-title":"The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction","volume":"284","author":"Sun","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2013.01.008_bb0175","doi-asserted-by":"crossref","first-page":"48474","DOI":"10.1074\/jbc.M301350200","article-title":"The phospholipase C\u03b31-dependent pathway of Fc\u03b5RI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase","volume":"278","author":"Tkaczyk","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2013.01.008_bb0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/blood-2003-08-2769","article-title":"NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and Fc\u03b5RI aggregation","volume":"104","author":"Tkaczyk","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jim.2013.01.008_bb0185","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1182\/blood.V99.9.3342","article-title":"Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration","volume":"99","author":"Ueda","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jim.2013.01.008_bb0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/MCB.01153-06","article-title":"Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling","volume":"27","author":"Xiang","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jim.2013.01.008_bb0195","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1182\/blood-2010-05-287821","article-title":"Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production","volume":"117","author":"Zhang","year":"2011","journal-title":"Blood"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591300032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591300032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T06:29:44Z","timestamp":1714890584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002217591300032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S002217591300032X"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2013.01.008","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}